Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

NCT05354557

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Followup) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent and Follow up) Commack, New York, United States
View Trial Details
Active, not recruiting

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

NCT02797470

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +41 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, not recruiting

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

NCT04662255

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • Arizona Oncology Associates, P.C. - HOPE Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • USO-Rocky Mountain Cancer Center Denver, Colorado, United States
View all 189 locations
View Trial Details
Active, not recruiting

Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone

NCT03104842

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Vivantes Am Urban Berlin, Germany
  • Campus Benjamin Franklin Charite Berlin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
  • Städt. Kliniken Bielefeld Klinikum Mitte Bielefeld, Germany
View all 17 locations
View Trial Details
Active, not recruiting

A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

NCT07134088

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • Lucile Packard Childrens Hospital Stanford Palo Alto, California, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • St Jude Childrens Research Hospital Memphis, Tennessee, United States
  • Seattle Childrens Hospital Seattle, Washington, United States
View Trial Details
Active, not recruiting

CLL Therapy Approaches in Russia

NCT05140369

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Belgorod, Russia
  • Research Site Bryansk, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Chita, Russia
View all 34 locations
View Trial Details

Related conditions